Financial statements Polimed Research
Balance sheet data of POLIMED RESEARCH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 12 957 699,97 | 14 565 518,16 | 14 592 825,48 | 19 044 489,11 | 14 504 052,03 |
| A. Fixed assets | 1 757 291,16 | 1 208 592,33 | 1 228 231,70 | 3 382 904,52 | 4 043 084,16 |
| B. Current assets | 11 200 408,81 | 13 356 925,83 | 12 801 093,78 | 15 661 584,59 | 10 460 967,87 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 563 500,00 | 0,00 | 0,00 |
| Total liabilities | 12 957 699,97 | 14 565 518,16 | 14 592 825,48 | 19 044 489,11 | 14 504 052,03 |
| A. Equity | 4 938 895,79 | 6 735 133,47 | 6 639 649,06 | 5 514 780,86 | 5 709 151,99 |
| B. Liabilities and provisions for liabilities | 8 018 804,18 | 7 830 384,69 | 7 953 176,42 | 13 529 708,25 | 8 794 900,04 |
| I. Long-term liabilities | 949 881,12 | 568 702,29 | 731 533,17 | 1 400 079,16 | 597 052,24 |
| II. Short-term liabilities | 6 363 164,03 | 6 800 329,40 | 6 968 326,31 | 6 736 325,05 | 6 268 998,56 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.